FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387109651> ?p ?o ?g. }

• W4387109651 endingPage "4708" @default.
• W4387109651 startingPage "4689" @default.
• W4387109651 abstract "Nucleolar and spindle-associated protein 1 (NUSAP1) is a microtubule-associated protein that plays a crucial role in mitosis. Despite initial reports suggesting a potential involvement of NUSAP1 in tumor progression and malignant cell regulation, there has been no systematic analysis of its role in the tumor immune microenvironment, nor its predictive value for prognosis and immunotherapy response across different cancer types. In this study, we analyze NUSAP1 mRNA and protein expression levels in various human normal and tumor tissues, using data from TCGA, GTEx, CPTAC, HPA databases, and clinical samples. Our findings reveal that NUSAP1 is highly expressed in multiple tumor tissues across most cancer types and is primarily expressed in malignant and immune cells, according to single-cell sequencing data from the TISCH database. Prognostic analysis based on curated survival data from the TCGA database indicates that NUSAP1 expression levels can predict clinical outcomes for 26 cancer types. Furthermore, Gene Set Enrichment Analysis (GSEA) suggests that NUSAP1 promotes cell proliferation, tumor cell invasion, and regulation of anti-tumor response. Analysis of immune score, immune cell infiltration, and anti-cancer immunity cycle using ESTIMATE, TIMER, and TIP databases show that high NUSAP1 levels are associated with low CD4+T and NKT cell infiltration but high Th2 and MDSC infiltration, inversely correlated with antigen-presenting molecules and positively correlated with a variety of immune negative regulatory molecules. Notably, patients with melanoma, lung, and kidney cancer with high NUSAP1 expression levels have shorter survival times and lower immunotherapy response rates. Using Cmap analysis, we identify Entinostat and AACOCF3 as potential inhibitors of NUSAP1-mediated pro-oncogenic effects. In vitro and in vivo experiments further confirm that NUSAP1 knockdown significantly reduces the proliferation ability of A549 and MCF-7 cells. Overall, our study highlights the potential of NUSAP1 expression as a novel biomarker for predicting prognosis and immuno-therapeutic efficacy across different human cancers and suggests its potential for developing novel antitumor drugs or improving immunotherapy." @default.
• W4387109651 created "2023-09-28" @default.
• W4387109651 creator A5004781962 @default.
• W4387109651 creator A5013518754 @default.
• W4387109651 creator A5034634872 @default.
• W4387109651 creator A5047043019 @default.
• W4387109651 creator A5057115300 @default.
• W4387109651 creator A5065482772 @default.
• W4387109651 creator A5065698591 @default.
• W4387109651 creator A5072699872 @default.
• W4387109651 creator A5086294527 @default.
• W4387109651 creator A5090875147 @default.
• W4387109651 date "2023-01-01" @default.
• W4387109651 modified "2023-10-05" @default.
• W4387109651 title "Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response" @default.
• W4387109651 cites W1910908492 @default.
• W4387109651 cites W2009824440 @default.
• W4387109651 cites W2023469279 @default.
• W4387109651 cites W2066671159 @default.
• W4387109651 cites W2102685625 @default.
• W4387109651 cites W2130027352 @default.
• W4387109651 cites W2136961873 @default.
• W4387109651 cites W2225942893 @default.
• W4387109651 cites W2410541021 @default.
• W4387109651 cites W2560367415 @default.
• W4387109651 cites W2587048937 @default.
• W4387109651 cites W2606765235 @default.
• W4387109651 cites W2795867722 @default.
• W4387109651 cites W2884754721 @default.
• W4387109651 cites W2889052854 @default.
• W4387109651 cites W2979651377 @default.
• W4387109651 cites W2995903778 @default.
• W4387109651 cites W3008647972 @default.
• W4387109651 cites W3016588471 @default.
• W4387109651 cites W3038011253 @default.
• W4387109651 cites W3044737312 @default.
• W4387109651 cites W3045946240 @default.
• W4387109651 cites W3119561596 @default.
• W4387109651 cites W3119799512 @default.
• W4387109651 cites W3126648948 @default.
• W4387109651 cites W3127929019 @default.
• W4387109651 cites W3169600697 @default.
• W4387109651 cites W3169609118 @default.
• W4387109651 cites W3183874515 @default.
• W4387109651 cites W3193029538 @default.
• W4387109651 cites W3194570062 @default.
• W4387109651 cites W3195143313 @default.
• W4387109651 cites W3197145976 @default.
• W4387109651 cites W3202545704 @default.
• W4387109651 cites W3206496593 @default.
• W4387109651 cites W3209712451 @default.
• W4387109651 cites W3211842141 @default.
• W4387109651 cites W3213295335 @default.
• W4387109651 cites W4206841660 @default.
• W4387109651 cites W4221020838 @default.
• W4387109651 cites W4225130516 @default.
• W4387109651 cites W4225484942 @default.
• W4387109651 cites W4226037523 @default.
• W4387109651 cites W4226172846 @default.
• W4387109651 cites W4229333937 @default.
• W4387109651 cites W4283324688 @default.
• W4387109651 cites W4283716866 @default.
• W4387109651 doi "https://doi.org/10.7150/ijbs.80017" @default.
• W4387109651 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37781040" @default.
• W4387109651 hasPublicationYear "2023" @default.
• W4387109651 type Work @default.
• W4387109651 citedByCount "0" @default.
• W4387109651 crossrefType "journal-article" @default.
• W4387109651 hasAuthorship W4387109651A5004781962 @default.
• W4387109651 hasAuthorship W4387109651A5013518754 @default.
• W4387109651 hasAuthorship W4387109651A5034634872 @default.
• W4387109651 hasAuthorship W4387109651A5047043019 @default.
• W4387109651 hasAuthorship W4387109651A5057115300 @default.
• W4387109651 hasAuthorship W4387109651A5065482772 @default.
• W4387109651 hasAuthorship W4387109651A5065698591 @default.
• W4387109651 hasAuthorship W4387109651A5072699872 @default.
• W4387109651 hasAuthorship W4387109651A5086294527 @default.
• W4387109651 hasAuthorship W4387109651A5090875147 @default.
• W4387109651 hasBestOaLocation W43871096511 @default.
• W4387109651 hasConcept C104317684 @default.
• W4387109651 hasConcept C121608353 @default.
• W4387109651 hasConcept C143998085 @default.
• W4387109651 hasConcept C150194340 @default.
• W4387109651 hasConcept C18431079 @default.
• W4387109651 hasConcept C203014093 @default.
• W4387109651 hasConcept C2776107976 @default.
• W4387109651 hasConcept C2776256026 @default.
• W4387109651 hasConcept C2777701055 @default.
• W4387109651 hasConcept C2780674031 @default.
• W4387109651 hasConcept C2781197716 @default.
• W4387109651 hasConcept C502942594 @default.
• W4387109651 hasConcept C54355233 @default.
• W4387109651 hasConcept C70721500 @default.
• W4387109651 hasConcept C71924100 @default.
• W4387109651 hasConcept C86803240 @default.
• W4387109651 hasConcept C8891405 @default.
• W4387109651 hasConceptScore W4387109651C104317684 @default.
• W4387109651 hasConceptScore W4387109651C121608353 @default.

• next